PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic

By Topic

RemSense Technologies (ASX: REM)

RemSense Technologies (ASX: REM): Director Options Plan Puts Pay and Dilution in Focus

Oct 21, 2026
Proactive Equities Team

RemSense Technologies (ASX: REM) will ask shareholders to approve 45 million unlisted options for its three directors at its 30 October AGM, a move that would dilute existing holders by about 15.6% if fully exercised, alongside an auditor appointment.

Dateline Resources (ASX: DTR)

Dateline Resources (ASX: DTR): Colosseum’s Gold Reserves Offer Significant Upside, but Legal and Development Risks Remain

Oct 21, 2026
Proactive Equities Team

Dateline Resources (ASX: DTR) holds 100% of Colosseum, with a 573,000oz gold reserve and A$86.0 million cash. An August 2026 court injunction halted activities, creating legal and financing risks. Colosseum is valued at US$380 million to US$727 million.

Norwood Systems (ASX: NOR)

Norwood Systems (ASX: NOR): Driving Next-Gen Voice AI Solutions with Oversubscribed Note Financing

Oct 20, 2026
Proactive Equities Team

Norwood Systems (ASX: NOR) raised $695,000 through an oversubscribed convertible note as its OpenSpan Voice AI pilots with Tier-1 telecom operators advance, after FY26 revenue rose 22% to $2.32 million.

Starpharma Holdings (ASX: SPL)

Starpharma Holdings (ASX: SPL): Petalion Stake Increase Puts Oncology Pipeline in Focus

Oct 20, 2026
Proactive Equities Team

Starpharma Holdings (ASX: SPL) has increased its stake in Petalion Therapeutics to 66%, gaining majority ownership of its FAP-targeted oncology program and allocating up to A$5 million to advance drug development and support future partnering opportunities.

Adisyn (ASX: AI1)

Adisyn (ASX: AI1): 10 Million Performance Rights Hand New Graphene Chief a Revenue Test

Oct 20, 2026
Proactive Equities Team

Adisyn (ASX: AI1) has appointed former Tower Semiconductor COO Ephraim Koltin to lead its graphene subsidiary, with up to 10 million performance rights tied to customer contracts, revenue and share price hurdles that will define how commercial progress is judged.

Eminence Minerals (ASX: EMA)

Eminence Minerals (ASX: EMA): Gold Expansion in Côte d’Ivoire and Rare Earths Progress in Brazil

Oct 20, 2026
Proactive Equities Team

Eminence Minerals (ASX: EMA) has entered into option agreements to acquire interests in five gold projects in Côte d’Ivoire while advancing rare earth exploration in Brazil, with assay results and shareholder approval for a proposed share issuance among key upcoming milestones.

...

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...456...82
Page 5 of 82